FoxM1 regulates Sirt1 expression in glioma cells

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 2, 2014, Pages 205-211

  Zhu, G Y ^a   Shi, B Z ^a   Li, Y ^b  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

FoxM1; Glioma; mRNA transcription; Promoter; Sirt1

Indexed keywords

FORKHEAD BOX M1; MESSENGER RNA; SIRTUIN 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CHROMATIN IMMUNOPRECIPITATION; GLIOMA CELL; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANSCRIPTION FACTORS;

EID: 84896984997     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. GIGINEISHVILI D, SHENGELIA N, SHALASHVI LI G, ROHRMANN S, TSISKARIDZE A, SHAKARISHVILI R. Primary brain tumour epidemiology in Georgia: first-year results of a population-based study. J Neurooncol 2013; 112: 241-246.
2. MEHTA S, HUILLARD E, KESARI S, MAIRE CL, GOLEBIOWSKI D, HARRIGTON EP, ALBERTA JA, KANE MF, THEISEN M, LIGON KL, ROWITCH DH, STILES CD. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell 2011; 19: 359-371.
3. HOTTINGER AF, HOMICSKO K, NEGRETTI L, LHERMITTE B, STUPP R. Decision making and management of gliomas: practical considerations. Ann Oncol 2012; 10: x33-40.
4. WONSEY DR, FOLLETTIE MT. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 2005; 65: 5181-5189.
5. RADHAKRISHNAN SK, BHAT UG, HUGHES DE, WANG IC, COSTA RH, GARTEL AL. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. Cancer Res 2006; 66: 9731-9735.
6. TEH MT, GEMENETZIDIS E, CHAPLIN T, YOUNG BD, PHILPOTT MP. Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes. Mol Cancer 2010; 9: 45.
7. ZENG J, WANG L, LI Q, LI W, BJÖRKHOLM M, JIA J, XU D. FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol 2009; 218: 419-427.
8. LI Q, ZHANG N, JIA Z, LE X, DAI B, WEI D, HUANG S, TAN D, XIE K. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res 2009; 69: 3501-3509.
9. GONG A, HUANG S. FoxM1 and Wnt/β-catenin signaling in glioma stem cells. Cancer Res 2012; 72: 5658-5662.
10. CHENG SX, TU Y, ZHANG S. FoxM1 promotes glioma cells progression by up-regulating anxa1 expression. PLoS One 2013; 8: e72376.
11. LI Y, ZHANG S, HUANG S. FoxM1: a potential drug target for glioma. Future Oncol 2012; 8: 223-226.
12. CHALKIADAKI A, GUARENTE L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol 2012; 8: 287-296.
13. BROOKS CL, GU W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009; 9: 123-128.
14. KIM YH, CHOI MH, KIM JH, LIM IK, PARK TJ. C-terminus-deleted FoxM1 is expressed in cancer cell lines and induces chromosome instability. Carcinogenesis 2013; 34: 1907-1917.
15. WANG R, ZHANG, KIM HS, XU X, CAO L, LUHASEN T, LEE MX, XIAO C, VASSILOPOULOS A, CHEN W, GARDNER K, MAN YG, HUNG MC, FINKEL T, DENG CX. Interplay among BRCA1, SIRT1, and survivin during BRCA1-associated tumorigenesis. Mol Cell 2008; 32: 11-20.
16. FIRESTEIN R, BLANDER G, MICHAN S, OBERDOERFFER P, OGINO S, CAMPBELL J, BHIMAYARAPU A, LUIKENHUIS S, DE CABO R, FUCHS C, HAHN WC, GUARENTE LP, SINCLAIR DA. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PloS One 2008; 3: e2020.
17. ELANGOVAN S, RAMACHANDRAN S, VENKATESAN N, ANANTH S, GNANA-PRAKASAM JP, MARTIN PM, BROWNING DD, SCHOENLEIN PV, PRASAD PD, GANAPATHY V, THANGARAJU M. SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor a in breast cancer. Cancer Res 2011; 71: 6654-6664.
18. PORTMANN S, FAHRNER R, LECHLEITER A, KEOGH A, OVERNEY S, et al. Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo. Mol Cancer Ther 2013; 12: 499-508.
19. QU Y, ZHANG J, WU S, LI B, LIU S, CHENG J. SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines. Neurosci Lett 2012; 525: 168-172.
20. MA JX, LI H, CHEN XM, YANG XH, WANG Q, WU ML, KONG QY, LI ZX, LIU J. Expression patterns and potential roles of SIRT1 in human medulloblastoma cells in vivo and in vitro. Neuropathology 2013; 33: 7-16.
21. CHANG CJ, HSU CC, YUNG MC, CHEN KY, TZAO C, et al. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochem Biophys Res Commun 2009; 380: 236-242.
22. SAYD S, THIRANT C, EL-HABR EA, LIPECKA J, DUBOIS LG, BOGEAS A, TAHIRI-JOUTI N, CHNEIWEISS H, JUNIER MP. Sirtuin-2 activity is required for glioma stem cell proliferation arrest but not necrosis induced by resveratrol. Stem Cell Rev 2013 Aug 18. [Epub ahead of print]
23. MILLOUR J, DE OLANO N, HORIMOTO Y, MONTEIRO LJ, LANGER JK, ALIGUE R, HAJII N, LAM EWF. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance. Mol Cancer Ther 2011; 10: 1046-1058.